BMS is spinning out a new company with five immunology assets, including oral drugs being developed for systemic lupus ...

The autoimmune disorder systemic lupus erythematosus (SLE) involves upregulation of IgD, and studies have shown that anti-IgD antibodies can alleviate the autoimmune disorder rheumatoid arthritis in ...

Introduction: Systemic lupus erythematosus (SLE) is an autoimmune disease with clinical and laboratory heterogeneity. Data on cutaneous vasculitis (CV) in SLE are limited, especially in the context of ...

The use of hydroxychloroquine in patients with lupus nephritis is linked to kidney function benefits, especially in those with chronic kidney disease stage ≥ 3.

The Lupus Foundation of America, the national force devoted to solving the cruel mystery of lupus, announced the appointment ...

Lupus Foundation of America and Lupus Canada award research grant to study aiming to uncover the causes of fatigue in people with lupus: Washington, DC Monday, July 28, 2025, 10:0 ...

Although obinutuzumab has not yet received FDA approval in lupus nephritis, findings from a recent survey conducted by ...

UCSF researchers have found that certain antiviral genes become less active over time in lupus, revealing why some patients see their symptoms fade as they age.

Identifying early predictors of chronic kidney disease (CKD) progression in patients with lupus nephritis may help define a high-risk group.

UCSF researchers have found that certain antiviral genes become less active over time in lupus, revealing why some patients ...

Discover how Obexelimab's unique B-cell inhibition and pivotal Phase 3 IgG4 results could drive Zenas BioPharma, Inc.'s ...

US pharma major Bristol Myers Squibb and Bain Capital announced the creation of a new independent biopharmaceutical company ...